EC
Euclidean Capital Portfolio holdings
AUM
$306M
This Quarter Return
-1.88%
1 Year Return
+16.69%
3 Year Return
+17.66%
5 Year Return
–
10 Year Return
–
AUM
$737M
AUM Growth
+$737M
(-19%)
Cap. Flow
-$154M
Cap. Flow
% of AUM
-20.93%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
12
New
–
Increased
1
Reduced
1
Closed
1
Top Buys
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$29M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$180M |
| 2 |
ME
23andMe Holding Co. Class A Common Stock
ME
|
$3.59M |
Sector Composition
| 1 | Healthcare | 3.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR S&P 500 ETF Trust
SPY
$658B
| $525M | 71.3% |
896,254
-306,550
| -25% | -$180M |
|
2
iShares MSCI India ETF
INDA
$9.17B
| $128M | 17.33% |
2,425,144
| – | – |
|
|
3
Vanguard FTSE All-World ex-US ETF
VEU
$48.6B
| $58.2M | 7.9% |
1,013,434
+505,834
| +100% | +$29M |
|
4
Oric Pharmaceuticals
ORIC
$994M
| $7.98M | 1.08% |
989,410
| – | – |
|
5
Foghorn Therapeutics
FHTX
$286M
| $7.43M | 1.01% |
1,573,761
| – | – |
|
6
PMV Pharmaceuticals
PMVP
$74.2M
| $3.97M | 0.54% |
2,627,643
| – | – |
|
7
Alector
ALEC
$238M
| $2.47M | 0.34% |
1,307,858
| – | – |
|
8
Tenaya Therapeutics
TNYA
$184M
| $1.45M | 0.2% |
1,015,705
| – | – |
|
9
Surrozen
SRZN
$104M
| $1.26M | 0.17% |
87,696
| – | – |
|
10
RAPT Therapeutics
RAPT
$188M
| $1.04M | 0.14% |
657,899
| – | – |
|
|
11
Surrozen, Inc. Warrant
SRZNW
$71.6K
| $3.66K | ﹤0.01% |
170,833
| – | – |
|
|
ME
12
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| – | – |
-10,243,122
| Closed | -$3.59M |
|